Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Turkey key underlying issue as Israel, Greece, Cyprus hold summit - 2The cheap health insurance promoted by Trump officials has this catch
- 3RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- 4A Couple of Reasonable Guitars for 2024
- 5RFK Jr. says he's following 'gold standard' science. Here's what to know
- Native Americans had dice and games of probability long before other cultures, study finds
- Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals
- Grass Care Administrations for a Wonderful, Sound Yard
- ABC News' Sam Champion opens up about recent health scare
- 'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
- Compassion and Association: Building Significant Connections
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- Environmental groups urge Germany to cut oil and gas dependence
- Blue Origin's next space tourism flight will break new ground for people with disabilities
